Pfizer.Com
Add to my board
ShareCompany
FilterKey facts
- City: New York
- State: NY
- Country: United States
- Sector: Health Care
- Foundation year: 1848
- Industry: Pharmaceuticals
- CEO: Dr. Albert Bourla D.V.M., DVM, Ph.D.
Latest news (see all)
A two-decade bet on a biotech company turned into a roughly $8 billion windfall for investors in the Baker Bros. Advisors hedge fund after Pfizer bought Seagen.
Read: The Wall Street Journal
2024-04-15
Pfizer wants the first FDA approval ever for an RSV vaccine for young adults
Read: Quartz
2024-04-09
Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use
Read: CNBC News
2024-04-09
Pfizer will raise about $3.5 billion from the sale of part of its stake in consumer-healthcare business Haleon.
Read: The Wall Street Journal
2024-03-20
Pfizer to Raise Around $3.5 Billion From Haleon Shares Sale
Read: The Wall Street Journal
2024-03-19
Pfizer to Raise Around $3.5 Billion From Haleon Shares Sale
Read: The Wall Street Journal
2024-03-19
Metrics
General information
Business
| assets | 181.5B $ |
| Debt | 36.4B $ |
| free cash flow | -135,792,000.00 |
| market cap | 136,223,000,000.00 |
| profits | 22B $ |
Visualizations
Datasets
Companies in the United States
Companies where Industry equals Pharmaceuticals
Companies where Sector equals Health Care
Stocks for Pfizer.Com
Source
Updated: 1 day ago
